Personalized Nutrition Is Here and It Works — But the Science Is More Complicated Than Companies Admit

Personalized nutrition services using glucose monitors and microbiome tests are booming. Here is what the actual clinical evidence shows about whether they work better than general advice.

The personalized nutrition market — companies selling blood glucose monitoring devices, microbiome sequencing, continuous glucose monitors, and AI-powered dietary recommendations tailored to individual biology — has grown dramatically on the basis of a genuinely interesting scientific observation: people's metabolic responses to identical foods vary enormously. Two people eating the same meal can show dramatically different blood glucose responses based on their individual gut microbiome composition, metabolic rate, and genetic factors.

This observation, documented in a landmark 2015 Weizmann Institute study and replicated by subsequent research, is real and its implications are significant. If blood glucose responses to foods vary this much between individuals, then one-size-fits-all dietary guidelines — telling everyone to eat less of X and more of Y — may be systematically optimal for the average but suboptimal for many individuals.

The specific question that clinical trials are now addressing is whether personalized nutrition guidance — when applied to real people's dietary choices based on individual metabolic data — produces better health outcomes than general evidence-based dietary guidelines. The evidence to date is mixed. Some trials show meaningful improvements in glycaemic control and weight management for people who receive personalised glucose-response-based dietary guidance. Others show that the improvement over general evidence-based advice is modest — suggesting that for most people, eating more vegetables, less ultra-processed food, and appropriately sized portions is the dominant factor, and personalisation is the marginal addition.

For the consumer market: the Kerry 2026 nutrition trends report notes that 'personalized menus and recommendations are increasingly shaped by OMICs and lifestyle data,' reflecting genuine commercial demand. The specific consumer value of these services may be behavioural rather than purely biological: knowing your individual glucose response to specific foods through real-time monitoring creates behavioural feedback loops that may change food choices more durably than abstract dietary guidelines, regardless of whether the personalised recommendations are biologically superior to general ones.